QA: AbbVie Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2019_AbbVie_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001551152, AbbVie Inc.

  xvar xval
0 AssetsCurrent 16,945,000,000
1 IntangibleAssetsNetIncludingGoodwill 36,896,000,000
2 PropertyPlantAndEquipmentNet 2,883,000,000
3 remainder_Assets 2,628,000,000
4 LiabilitiesCurrent 17,239,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 7,718,000,000
8 SellingGeneralAndAdministrativeExpense 7,399,000,000
9 ResearchAndDevelopmentExpense 10,753,000,000
10 remainder_Expenses 10,000,000
11 remainder_Revenues 32,753,000,000
12 remainder_NetIncome -1,186,000,000
13 remainder_ComprehensiveNetIncome 247,000,000
  yvar yval
0 Assets 59,352,000,000
1 Liabilities 17,239,000,000
2 Expenses 25,880,000,000
3 Revenues 32,753,000,000
4 StockholdersEquity 42,113,000,000
5 NetIncome 5,687,000,000
6 ComprehensiveNetIncome 5,810,500,000
7 BaseVar 68,328,500,000
8 EconomicCapitalRatio 2.04

Edgar->Model Mapping

Feature Distribution

Change over Time